StemCells, Inc. Reports Third Quarter Financial Results and Recent Highlights
03 nov. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Nov. 3, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
StemCells, Inc. Awarded $977,917 in Federal Grants
02 nov. 2010 15h25 HE
|
StemCells, Inc.
PALO ALTO, Calif., Nov. 2, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has been awarded cash grants by the U.S. government totaling $977,917 for projects related to...
StemCells, Inc. Advances to Second Clinical Trial in Batten Disease
28 oct. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Oct. 28, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has initiated a second clinical trial of its HuCNS-SC® product candidate (purified human...
StemCells, Inc. Reports Progress in Myelination Disorder Trial
07 oct. 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Oct. 7, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today provided an update on its ongoing Phase I clinical trial in Pelizaeus-Merzbacher Disease (PMD), a fatal...
StemCells, Inc.'s Technology Used to Create First Genetically Engineered Rat Derived From Rat Embryonic Stem Cells
31 août 2010 16h48 HE
|
StemCells, Inc.
PALO ALTO, Calif., Aug. 31, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that its technology was recently used by independent researchers to achieve the first genetically...
StemCells, Inc. Reports Breakthrough Using Human Neural Stem Cells to Restore Motor Function in Chronic Spinal Cord Injury
19 août 2010 07h30 HE
|
StemCells, Inc.
PALO ALTO, Calif., Aug. 19, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today the publication of new preclinical data demonstrating that the Company's proprietary human neural...
StemCells, Inc. Reports Second Quarter Financial Results and Highlights
10 août 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., Aug. 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel stem cell therapeutics and tools for use in stem...
StemCells, Inc. Announces $6 Million Equity Financing
30 juin 2010 08h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., June 30, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it has entered into an agreement to sell seven million shares of its common stock to Seaside 88,...
StemCells, Inc. Scientists to Make Three Presentations at International Society for Stem Cell Research Annual Meeting
17 juin 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., June 17, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that three of its scientists will make presentations at the International Society for Stem Cell...
StemCells, Inc.'s GS2-M(TM) Media Formulation Shown to Enhance Pluripotency of Human Stem Cells
10 juin 2010 09h00 HE
|
StemCells, Inc.
PALO ALTO, Calif., June 10, 2010 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that newly published independent research demonstrates that its GS2-M™ cell culture media...